MICRO CAP STOCKS CANADA SOFTWARE

The expectation was for earnings of 22 cents in the latest quarter.įunds from operations were a record $68.8-million or 46 cents per share, a 211-per-cent increase from the $22.1-million or 19 cents per share) generated a year ago. “The higher net income reflected increased revenues due to improving commodity prices and growth in production volumes,” the company stated. Net income was $31.2-million or 21 cents per share compared to $400,000 or nil per share a year earlier. The expectation was for $77-million, according to S&P Capital IQ. Revenue was $73.6-million up from $25.8-million a year earlier. ( FRU-T) announced a 33-per-cent dividend hike alongside its fourth-quarter and full-year financial results. CloudMD also said it has added several contracts within the public sector division including for a major college employer in Atlantic Canada and mental health coaching for the employees of a major Ontario university.įreehold Royalties Ltd. The contracts include agreements to provide integration and technology services to the New York City Department of Education, a substance use disorder solution to support the opioid crisis in North Carolina, and more than 100 new contracts to provide mental health support covering up to 50,000 new employees under subscription services. ( DOC-X) announced a newly formed public sector division and recent customer contracts across North America that it says will provide “meaningful revenue diversification” and “opportunities to accelerate technology and service integration.”

MICRO CAP STOCKS CANADA SOFTWARE

( HITI-X) announced it’s buying four operating retail cannabis stores in Ontario under the name Crossroads Cannabis for $2.5-million.ĬloudMD Software & Services Inc. The companies estimated that total savings, which will be shared equally, are expected to be up to $50-million within two years. The deal will also see Tilray Brands and Hexo create a joint venture that will provide shared services to both companies. The conversion price implies that Tilray Brands would have the right to convert the notes into a 37-per-cent stake in Hexo. The notes will be amended to allow Tilray Brands to exercise conversion rights at a price of 90 cents Canadian per Hexo share. Under the agreement, Tilray Brands will acquire up to US$211-million of senior secured convertible notes that were issued by Hexo and are held by funds affiliated with HT Investments MA LLC. Net income of US$629.4-million or US$6.40 per share versus net income of US$48.6-million or 48 cents a year earlier.Ĭannabis company Tilray Brands Inc. ( TLRY-T) has signed a deal to take a stake in rival Hexo Corp. ( HEXO-T) and launch a strategic partnership with the company. ( FEC-T) reported sales of US$249.5-million up from US$155.3-million a year earlier. Net income for the period was $69.4-million or $2.38 per share compared to $24.3-million or 81 cents in the prior year.The expectation was for revenue of $1.1-billion and earnings of 79 cents per share.įrontera Energy Corp. ( ACQ-T) reported record fourth quarter of just under $1.2-billion compared to $876.1- million in the prior year. Total vehicles1 sold were 20,296, an increase of 19.6 per cent. Used retail vehicles sold increased by 4,504 or 61 per cent. Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.ĪutoCanada Inc. The stock was trading 33.25% higher at $2.70 at the time of publication.Please log in to bookmark this story. It has also reported preclinical data from several candidates targeting other infectious diseases such as malaria and anthrax.

The company said its investigational asset DPX-RSV demonstrated a favorable safety profile and immunogenicity in older adults in a Phase 1 study. IMV said it intends to develop DPX-COVID-19 in collaboration with lead investigators for the Phase 1 clinical study of DPX-RSV, who will assist with preclinical and clinical evaluation and further development in collaboration with the Canadian government and others. 'We believe this technology offers a meaningful solution as a potential vaccine, especially in older adults and those with pre-existing conditions who are most at risk to this virus and generally more difficult to vaccinate effectively,' CEO Frederic Ors said in a statement.

Micro cap stocks canada